Read the official EU tenders document below, which states:
“The MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs)“. They already know this vaccine is harmful to human health!
https://ted.europa.eu/udl?uri=TED:NOTICE:506291-2020:TEXT:EN:HTML&tabId=1
United Kingdom-London: Software package and information systems
2020/S 207-506291
Contract award notice
Results of the procurement procedure
Supplies
Directive 2014/24/EU
Section I: Contracting authority
I.1)Name and addresses
Town: London
NUTS code: UK UNITED KINGDOM
Postal code: E14 4PU
Country: United Kingdom
E-mail: purchasing@mhra.gov.uk
Telephone: +44 2030806000
Internet address(es):
Main address: https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
I.4)Type of the contracting authority
I.5)Main activity
Section II: Object
II.1.1)Title:
SafetyConnect — AI
II.1.2)Main CPV code
II.1.3)Type of contract
II.1.4)Short description:
The MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs) and ensure that no details from the ADRs’ reaction text are missed.
II.1.6)Information about lots
II.1.7)Total value of the procurement (excluding VAT)
II.2.2)Additional CPV code(s)
II.2.3)Place of performance
II.2.4)Description of the procurement:
The MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs) and ensure that no details from the ADRs’ reaction text are missed.
II.2.5)Award criteria
II.2.11)Information about options
II.2.13)Information about European Union funds
Section IV: Procedure
IV.1.1)Type of procedure
- The procurement falls outside the scope of application of the directive
For reasons of extreme urgency under Regulation 32(2)(c) related to the release of a Covid-19 vaccine MHRA have accelerated the sourcing and implementation of a vaccine specific AI tool.
Strictly necessary — it is not possible to retrofit the MHRA’s legacy systems to handle the volume of ADRs that will be generated by a Covid-19 vaccine. Therefore, if the MHRA does not implement the AI tool, it will be unable to process these ADRs effectively. This will hinder its ability to rapidly identify any potential safety issues with the Covid-19 vaccine and represents a direct threat to patient life and public health.
Reasons of extreme urgency — the MHRA recognises that its planned procurement process for the SafetyConnect programme, including the AI tool, would not have concluded by vaccine launch. Leading to a inability to effectively monitor adverse reactions to a Covid-19 vaccine.
Events unforeseeable — the Covid-19 crisis is novel and developments in the search of a Covid-19 vaccine have not followed any predictable pattern so far.
IV.1.8)Information about the Government Procurement Agreement (GPA)
Section V: Award of contract
V.2.1)Date of conclusion of the contract:
V.2.2)Information about tenders
V.2.3)Name and address of the contractor
Town: London
NUTS code: UK UNITED KINGDOM
Country: United Kingdom
V.2.4)Information on value of the contract/lot (excluding VAT)
Section VI: Complementary information
VI.4.1)Review body
Town: London
Country: United Kingdom
VI.5)Date of dispatch of this notice: